Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD7+ Acute Leukemia”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Early research (Phase 1)WithdrawnNCT05513612
What this trial is testing

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more
Shanghai Pudong Hospital
Early research (Phase 1)Study completedNCT04840875
What this trial is testing

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 16
Early research (Phase 1)Looking for participantsNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Early research (Phase 1)UnknownNCT04599556
What this trial is testing

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

Who this might be right for
CD7+ Acute LeukemiaCD7+ Lymphoma
Zhejiang University 81
Early research (Phase 1)UnknownNCT04934774
What this trial is testing

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma
iCell Gene Therapeutics 20
Early research (Phase 1)Study completedNCT04572308
What this trial is testing

Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

Who this might be right for
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 20
Very early researchNot Yet RecruitingNCT07201727
What this trial is testing

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
AML - Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Testing effectiveness (Phase 2)UnknownNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Not applicableUnknownNCT04620655
What this trial is testing

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
T Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
Min Xiang 24
Very early researchWithdrawnNCT04860817
What this trial is testing

Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Not applicableStudy completedNCT04938115
What this trial is testing

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Who this might be right for
Leukemia, T Cell
Hebei Senlang Biotechnology Inc., Ltd. 50
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT02742727
What this trial is testing

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Who this might be right for
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaT-cell Prolymphocytic Leukemia+6 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885464
What this trial is testing

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Who this might be right for
Lymphoblastic LymphomaT-Cell Lymphoblastic Leukemia/LymphomaLymphoblastic Leukemia
Beam Therapeutics Inc. 5
Early research (Phase 1)Active Not RecruitingNCT05377827
What this trial is testing

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Who this might be right for
T-Cell Non-Hodgkin LymphomaAcute Myeloid LeukemiaAngioimmunoblastic T-cell Lymphoma+12 more
Washington University School of Medicine 6
Early research (Phase 1)Study completedNCT04984356
What this trial is testing

Of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Wugen, Inc. 28
Very early researchStudy completedNCT05907603
What this trial is testing

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Kai Lin Xu，MD 8
Very early researchNot Yet RecruitingNCT07476027
What this trial is testing

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

Who this might be right for
T Lymphoblastic LymphomaT Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Load More Results